Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00270933 · ClinicalTrials.gov registry record
MAVRIC VR ICD Registry
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 742
- Enrollment target
NCT00270933 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 742 participants.
The verdict
NCT00270933 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 742 participants
- Enrollment target
Study Summary
The purpose of this registry is to collect information on the health status of patients receiving Marquis/Maximo VR Implantable Cardiac Defibrillators (ICDs), how the devices are being programmed and how this correlates to clinical patient outcome.
Interventions
- DEVICE Registry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 742 participants |
| Start Date | 2004-01 |
| Est. Completion | 2005-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00270933
The ClinicalTrials.gov registry entry for NCT00270933 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 742 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Registry is the first listed.
NCT00270933 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00270933 about?
NCT00270933 is a clinical study titled "MAVRIC VR ICD Registry". The purpose of this registry is to collect information on the health status of patients receiving Marquis/Maximo VR Implantable Cardiac Defibrillators (ICDs), how the devices are being programmed and how this correlates to clinical patient outcome.
What is the current status of trial NCT00270933?
This trial is currently completed. The enrollment target is 742 participants. The study started on 2004-01. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00270933?
The interventions under investigation include: Registry (DEVICE).
Who is sponsoring clinical trial NCT00270933?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.